Type to search

The PanDIA-1 Study, for Early Detection of Pancreatic Cancer in Newly Onset Type 2 Diabetics, Moves Into Next Phase | Pharmtech Focus
Immunovia Appoints Jeff Borcherding, Previously Chief Marketing Officer at Myriad Genetics, to Lead Immunovia's US Business | Pharmtech Focus
Immunovia Further Strengthens IP Portfolio for its IMMray ™ PanCan-d Signature | Pharmtech Focus